Aust J Gen Pract
'Think Hep B' in primary care: A before-and-after evaluation of a self-guided learning package.
Xiao Y, van Gemert C, Howell J, Adamson E, Towell V, Cowie BC, Thompson AJ, Hellard M
In Australia, over a third of individuals living with chronic hepatitis B (CHB) remain undiagnosed. Evidence suggests general practitioners (GPs) can ...
Read More
Source: PubMed
Nephron 2020 Jan 31
Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol.
Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ
The impact of pretransplant donor-specific antibodies (DSAs), especially class II DSAs, on kidney allograft outcomes remains unclear in simultaneous l ...
Read More
Source: PubMed
J. Clin. Virol.
Four-year long (2014-2017) clinical and laboratory surveillance of hepatitis E virus infections using combined antibody, molecular, antigen and avidity detection methods: Increasing incidence and chronic HEV case in Hungary.
Pankovics P, Némethy O, Boros Á, Pár G, Szakály P, Reuter G
Hepatitis E virus (HEV) is a pathogen of viral hepatitis. Since 2006, the number of reported HEV cases has ten-fold increase in Hungary. ...
Read More
Source: PubMed
J. Clin. Virol.
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation.
Jordan AE, Perlman DC, Cleland CM, Wyka K, Schackman BR, Nash D
Hepatitis C virus (HCV) infection is the most prevalent blood-borne infection and causes more deaths than any other infectious disease in the US. Inci ...
Read More
Source: PubMed
Mol. Immunol.
Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.
Kardani K, Hashemi A, Bolhassani A
A licensed vaccine against human immunodeficiency virus-1 (HIV-1) infection has not become available up to now. Hence, it is more rational to use immu ...
Read More
Source: PubMed
